In this review, we highlight the role of NLRP3 inflammasome in DKD, and the pathways by which natural products fight against DKD via inhibiting the NLRP3 inflammasome activation, so as to offer novel insights for the treatment of DKD. This evidence concerns the gene NLRP3 and diabetic kidney disease.